ziyad al aly glp 1 Study: GLP-1s 'hold promise' for treating a wide range of diseases and health outcomes GLP-1 Medications Get at the

10.1016/j.neuroscience.2018.03.034 [DOI] [PubMed] [Google Scholar] Yu H., Wang D

Since there are many patients with T2D that cannot be controlled by previously developed drugs, it has been necessary to develop new drugs, one of which is a glucagon-like peptide-1 (GLP-1) based therapy

Initial authorization is usually given for 6-8 months

GLP-1 Effects on Appetite Regulation GLP-1R is expressed in the lateral hypothalamus (LH), where animal studies have shown that activation of these receptors decreases appetite [126]

Collectively, the systems summarized in Table 2 demonstrate that the metabolic peptide landscape beyond incretins is rich in validated biology but limited in translational follow-through

Still, the GLP-1 medication had greatly propelled him through the final leg of his journey by acting as a major appetite suppressant